The Scripps Molecular Screening Center and Translational Research Institute

@article{Baillargeon2019TheSM,
  title={The Scripps Molecular Screening Center and Translational Research Institute},
  author={Pierre Baillargeon and Virneliz Fern{\'a}ndez-Vega and Banupriya Sridharan and Steven J Brown and Patrick R. Griffin and Hugh Rosen and Benjamin F. Cravatt and Louis Scampavia and Timothy P. Spicer},
  journal={SLAS Discovery},
  year={2019},
  volume={24},
  pages={386 - 397}
}
The Scripps Research Molecular Screening Center (SRMSC) was founded in 2004 and comprises more than $22 million of specialized automation. As part of the Translational Research Institute (TRI), it comprises early drug discovery labs and medicinal chemistry. Together with Scripps Research at the La Jolla, California, campus, this represents one of the most competitive academic industrial screening centers worldwide. The SRMSC uses automated platforms, one a screening cell and the other a cherry… 

Figures from this paper

The Academic Pill: How Academia Contributes to Curing Diseases
  • M. Bickle
  • Biology
    SLAS discovery : advancing life sciences R & D
  • 2019
TLDR
A snapshot of the research being conducted in academic screening laboratories and in translational drug discovery centers is offered, which illustrates that academia is a rich source for novel assays as basic research is transformed into screens, leading to unexplored therapeutic avenues.
Development and pilot screen of novel high content assay for down regulators of expression of heterogenous nuclear ribonuclear protein H2
TLDR
This assay is thus capable of identifying authentic down regulators of hnRNPH1 and 2 in a large compound collection and, therefore, is amenable to a large-scale screening effort.
Identification of Potent Small Molecule Inhibitors of SARS-CoV-2 Entry
TLDR
Calpeptin is revealed as a potent and specific inhibitor of SARS-CoV-2 and some variants, highlighting the need for small molecule inhibitors of virus entry into target cells.
Identification of potent small molecule inhibitors of SARS-CoV-2 entry
Discovery and Optimization of Selective Inhibitors of Meprin α (Part I)
TLDR
Five selective inhibitors of meprin α belonging to three different chemotypes demonstrated a nanomolar to micromolar inhibitory activity against mePRin α with low cytotoxicity and >30-fold selectivity against mePrin β and other related metzincincs.
Identification of novel modulators of a schistosome transient receptor potential channel targeted by praziquantel
TLDR
Optimized methods to miniaturize a Ca2+-based reporter assay for Schistosoma mansoni TRPMPZQ activity enabling a high throughput screening (HTS) approach and underscores the validity of TRPMpZQ as a druggable target for antischistosomal ligands.
Identification of Potential Modulators of the RGS7/Gβ5/R7BP Complex
TLDR
A novel strategy to pharmacologically target the interaction between RGS7/Gβ5 and R7BP protein complex is implemented, using a time-resolved fluorescence resonance energy transfer (FRET)-based high-throughput screening (HTS) assay that measures compound-mediated alterations in the FRET signal.
Screening for Modulators of Autism Spectrum Disorder Using Induced Human Neurons.

References

SHOWING 1-10 OF 21 REFERENCES
The Academic Pill: How Academia Contributes to Curing Diseases
  • M. Bickle
  • Biology
    SLAS discovery : advancing life sciences R & D
  • 2019
TLDR
A snapshot of the research being conducted in academic screening laboratories and in translational drug discovery centers is offered, which illustrates that academia is a rich source for novel assays as basic research is transformed into screens, leading to unexplored therapeutic avenues.
A Novel 3-dimensional High Throughput Screening Approach Identifies Inducers of a Mutant KRAS Selective Lethal Phenotype
TLDR
A high-throughput screening approach using a spheroid-based 3-dimensional culture format, thought to more closely reflect conditions experienced by cells in vivo, identified Proscillaridin A as a selective inhibitor of cells harboring the oncogenic KRasG12V allele.
Advanced Development of Primary Pancreatic Organoid Tumor Models for High-Throughput Phenotypic Drug Screening
TLDR
An HTS-compatible method that enables the consistent production of organoids in standard flat-bottom 384- and 1536-well plates by combining the use of a cell-repellent surface with a bioprinting technology incorporating magnetic force is described.
Drug Library Screening for the Identification of Ionophores That Correct the Mistrafficking Disorder Associated with Oxalosis Kidney Disease
TLDR
Three drugs were identified as potential pharmacoperones from this pilot screen, demonstrating the applicability of this assay for large-scale high-throughput screening.
Improved Scalability of Neuron-Based Phenotypic Screening Assays for Therapeutic Discovery in Neuropsychiatric Disorders
TLDR
This work industrialized primary neuronal culture production, which enabled the creation of scalable assays within functioning neural networks, and developed a panel of phenotypic assays based on culturing of primary neurons from genetically modified mice expressing HTS-compatible reporters that capture disease-relevant phenotypes.
Assay Establishment and Validation of a High-Throughput Screening Platform for Three-Dimensional Patient-Derived Colon Cancer Organoid Cultures
TLDR
The establishment of an automated platform in 384-well format for three-dimensional organoid cultures derived from colon cancer patients is described and the feasibility of using patient-derived tumor samples for high-throughput assays and their integration as disease-specific models in drug discovery is demonstrated.
Observations on screening-based research and some concerning trends in the literature.
  • J. Baell
  • Biology
    Future medicinal chemistry
  • 2010
TLDR
Wider awareness and recognition of these problematic compounds will help the academic drug-discovery community focus on and publish genuinely optimizable screening hits.
A 1536-Well 3D Viability Assay to Assess the Cytotoxic Effect of Drugs on Spheroids
TLDR
The design and implementation of a novel high-throughput screening (HTS)–compatible 1536-well plate assay that enables the parallel formation, size monitoring and viability assessment of 3D spheroids in a highly consistent manner is described.
...
1
2
3
...